Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayathri R

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Molecular Cancer Therapeutics|January 19, 2008
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionKatherine M Aird, Xiuyun Ding, Aris Baras, et al.
International Journal of Nanomedicine|September 13, 2017
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostarsBridget M Crawford, Ronnie L Shammas, Andrew M Fales, et al.
Journal of Clinical and Translational Science|May 5, 2021
An innovative educational program for addressing health disparities in translational cancer researchCarla E Oldham, M J Gathings, Gayathri R Devi, et al.
Preventive Medicine Reports|December 20, 2023
Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and managementGayathri R Devi, Laura J Fish, Alexandra Bennion, et al.
Evolution, Medicine, and Public Health|March 19, 2021
<i>Hymenolepis diminuta</i>-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progressionScott Sauer, Dylan Beinart, Sade M B Finn, et al.
Cancer Letters|May 22, 2013
Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitizationKevin P Williams, Jennifer L Allensworth, Shalonda M Ingram, et al.
Molecular Cancer Therapeutics|December 16, 2020
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent ApoptosisXuemei Xie, Jangsoon Lee, Huey Liu, et al.
Carcinogenesis|August 5, 2020
A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cellsLarisa M Gearhart-Serna, John B Davis, Mohit Kumar Jolly, et al.
Carcinogenesis|April 21, 2017
Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cellsScott J Sauer, Michael Tarpley, Imran Shah, et al.
Biomacromolecules|December 11, 2025
Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry <i>In Vivo</i>Weijing Chu, Gayathri R Ediriweera, Amber Prior, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|January 19, 2008
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionKatherine M Aird, Xiuyun Ding, Aris Baras, et al.
International Journal of Nanomedicine|September 13, 2017
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostarsBridget M Crawford, Ronnie L Shammas, Andrew M Fales, et al.
Journal of Clinical and Translational Science|May 5, 2021
An innovative educational program for addressing health disparities in translational cancer researchCarla E Oldham, M J Gathings, Gayathri R Devi, et al.
Preventive Medicine Reports|December 20, 2023
Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and managementGayathri R Devi, Laura J Fish, Alexandra Bennion, et al.
Evolution, Medicine, and Public Health|March 19, 2021
<i>Hymenolepis diminuta</i>-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progressionScott Sauer, Dylan Beinart, Sade M B Finn, et al.
Cancer Letters|May 22, 2013
Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitizationKevin P Williams, Jennifer L Allensworth, Shalonda M Ingram, et al.
Molecular Cancer Therapeutics|December 16, 2020
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent ApoptosisXuemei Xie, Jangsoon Lee, Huey Liu, et al.
Carcinogenesis|August 5, 2020
A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cellsLarisa M Gearhart-Serna, John B Davis, Mohit Kumar Jolly, et al.
Carcinogenesis|April 21, 2017
Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cellsScott J Sauer, Michael Tarpley, Imran Shah, et al.
Biomacromolecules|December 11, 2025
Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry <i>In Vivo</i>Weijing Chu, Gayathri R Ediriweera, Amber Prior, et al.
Pageof 12